ICER releases draft evidence report on novel agents to prevent chemotherapy-induced neutropenia

25 January 2022 - Registration now open for 1 February “Early Insights” webinar. Public comment period now open until 22 ...

Read more →

Advancing health through innovation: new drug therapy approvals 2021

13 January 2022 - The FDA’s Center for Drug Evaluation and Research has issued its report, Advancing Health Through Innovation: New ...

Read more →

PBAC Public Summary Documents – September 2021 meeting (first time rejections and deferrals)

14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...

Read more →

ICER publishes evidence report on tirzepatide for type 2 diabetes

6 January 2022 - Tirzepatide has a novel dual GIP and GLP-1 receptor agonist mechanism of action and is seen as ...

Read more →

Public Summary Documents – September 2021 PBAC meeting

24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...

Read more →

PBS expenditure and prescriptions report 2020-21

24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...

Read more →

Report on the collection of under co-payment data 2020-21

24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...

Read more →

Call for a central portal for clinical study reports

1 December 2021 - In an open-access publication in the Journal of European CME, two authors from IQWiG argue that ...

Read more →

Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology

25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...

Read more →

MTAA welcomes new frontiers report

25 November 2021 - The Medical Technology Association of Australia wishes to thank Trent Zimmerman MP and Dr Mike Freelander MP ...

Read more →

Semaglutide (Wegovy) stakeholder meeting outcome statement

24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...

Read more →

ICER publishes final evidence report and policy recommendations on mavacamten for hypertrophic cardiomyopathy

16 November 2021 - Concerns about long-term safety influenced majority of independent appraisal committee to vote that evidence is not currently ...

Read more →

Public Summary Documents (first time rejections and deferrals) – July 2021 PBAC meeting

12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...

Read more →

ICER releases draft evidence report on tirzepatide for type 2 diabetes mellitus

9 November 2021 - Public comment period now open until 8 December 2021; requests to make oral comment during public ...

Read more →

Drug Utilisation Sub-Committee outcome statement

5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...

Read more →